Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000019

President and Vant Chair sold 3,000,000 shares at an average $27.35 ($82,039,460)

  • President and Vant Chair acquired 3,000,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Torti Frank · President and Vant Chair

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-19 Exercise or conversion : show line 1 in the form 10b5-1 +1,400,000 $3.85 $5,390,000 15,136,547 D
2026-02-19 Sale : show line 2 in the form 10b5-1 −1,400,000 $27.42 $38,388,000 13,736,547 D
2026-02-20 Exercise or conversion : show line 3 in the form 10b5-1 +1,012,610 $3.85 $3,898,549 14,749,157 D
2026-02-20 Sale : show line 4 in the form 10b5-1 −1,012,610 $27.15 $27,492,362 13,736,547 D
2026-02-23 Exercise or conversion : show line 5 in the form 10b5-1 +587,390 $3.85 $2,261,452 14,323,937 D
2026-02-23 Sale : show line 6 in the form 10b5-1 −587,390 $27.51 $16,159,099 13,736,547 D
Open-market sales · 3,000,000 sh · avg $27.35 · $82,039,460

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-02-19 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −1,400,000 4,626,184 D
2026-02-20 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −1,012,610 3,613,574 D
2026-02-23 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) −587,390 3,026,184 D
Loading xslF345X05/wk-form4_1771897216.xml…